据港交所披露信息统计截至6月30日今年上半年共有10家生物医药企业成功登陆港交所而去年全年仅有12家。从具体行业分布看6

智通财经
04 Jul
据港交所披露信息统计截至6月30日今年上半年共有10家生物医药企业成功登陆港交所而去年全年仅有12家。从具体行业分布看6家属于医药生物行业4家属于医疗设备与服务行业两者分别位居上半年Wind各行业港股IPO发行数量的前两位。2025年开年以来多达39家医疗健康企业在港交所排队等待上市。另据德勤统计今年第一季度香港主板活跃申请上市个案达到118宗同比大幅增加其中医疗及医药行业占比达26%。港股医药IPO狂飙不仅表现在数量上还体现在募资总额上。据相关显示医药生物行业前六个月募资金额达到156亿港元是当期港股IPO募资规模第二高的行业显著高于过去三年的平均水平。展望2025年的下半场企业赴港IPO的劲头仍在继续有40余家生物医药企业在排队等待上市。(21财经)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10